FMI News Alert Foundation Medicine Inc (FMI) 48.88 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Foundation Medicine Inc (FMI) 48.88 $FMI

New Data from FoundationOne(R) Demonstrates Genomic Basis for Potential New Routes to Therapy and Improved Outcomes for Individuals with Cancers of Unknown Primary
Business Wire - Thu Feb 12, 10:00AM CST
--Data Published in Inaugural Issue of JAMA Oncology
FMI: 48.88 (+0.17)

Research and Markets: Industry Focus - Life Sciences: Vital Signs - The Analyst's Perspective - February 2015 Issue
Business Wire - Thu Feb 12, 6:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/7x827q/industry_focus) has announced the addition of the "Industry Focus - Life Sciences: Vital Signs - The Analyst's Perspective - 2015 Issue" report to their offering.
FMI: 48.88 (+0.17), NVS: 102.20 (-0.17)

Industry Focus - Life Sciences: Vital Signs - The Analyst's Perspective - February 2015 Issue
M2 - Thu Feb 12, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/g9nfb4/industry_focus) has announced the addition of the "Industry Focus - Life Sciences: Vital Signs - The Analyst's Perspective - 2015 Issue" report to their offering. This issue of Vital Signs, released on February 4, 2014, discusses Roche's collaboration with Foundation Medicine, Novartis' potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc. Overview: - Roche Enters a Broad, Strategic Collaboration with Foundation Medicine in the - Field of Molecular Information in Oncology - The Race Toward Longevity: A Dream Come True? - DNA Electronics Ltd. Acquires nanoMR Inc. for $24 million For more information visit http://www.researchandmarkets.com/research/g9...stry_focus
FMI: 48.88 (+0.17), NVS: 102.20 (-0.17)

Why Shares of Pacific Biosciences of California Inc. Tanked Today
George Budwell, The Motley Fool - Motley Fool - Wed Feb 04, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of Pacific Biosciences of California plunged...
PACB: 6.96 (-0.06), FMI: 48.88 (+0.17)

Foundation Medicine to Present at the Leerink Global Healthcare Conference
Business Wire - Wed Feb 04, 5:30AM CST
Foundation Medicine, Inc. (NASDAQ:FMI) today announced Steven Kafka, Ph.D., chief operating officer, is scheduled to present at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015, at 1:25 p.m. EST in New York City.
FMI: 48.88 (+0.17)

INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Foundation Medicine, Inc. In Connection With the Sale of a Majority Stake to Roche
Business Wire - Tue Feb 03, 4:40PM CST
Levi & Korsinsky commences an investigation into the Board of Directors of Foundation Medicine, Inc. ("Foundation Medicine" or "the Company" (NasdaqGS:FMI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of a majority stake in the Company to Roche Holding.
FMI: 48.88 (+0.17)

Foundation Med reports February 24
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 6:04AM CST

FMI: 48.88 (+0.17)

Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2014 Financial Results and Conference Call
Business Wire - Tue Feb 03, 5:30AM CST
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2014, will be released on Tuesday, February 24, 2015. The management team will host a conference call discussing the company's financial results and recent developments on Tuesday, February 24, 2015, at 4:30 p.m. ET. The call can be accessed by dialing 1-855-420-0652 (domestic) or 1-484-365-2939 (international) five minutes prior to the start of the call and providing the passcode 72249406.
FMI: 48.88 (+0.17)

Poor Pipeline Productivity Has Left Roche More Vulnerable
Stephen Simpson, CFA - at Seeking Alpha - Thu Jan 29, 4:07PM CST

FMI: 48.88 (+0.17), BMY: 60.04 (+0.56)

Short Interest Falls 41.2% For FMI
MarketNewsVideo.com - Wed Jan 28, 3:57PM CST
The most recent short interest data has been released by the NASDAQ for the 01/15/2015 settlement date, which shows a 2,054,747 share decrease in total short interest for Foundation Medicine Inc , to 2,935,845, a decrease of 41.17% since 12/31/2014. ...
FMI: 48.88 (+0.17)

Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Jan 16, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ZIOP: 9.64 (-0.35), ARWR: 6.77 (+0.21), XON: 39.30 (+1.05), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), MNKD: 7.00 (+0.02), RGDO: 1.17 (+0.02), HUM: 152.67 (-1.06), ETRM: 1.21 (+0.06), FMI: 48.88 (+0.17), GILD: 101.90 (+1.10), GERN: 3.03 (unch), SHPG: 239.82 (+6.11), SRPT: 12.76 (+0.11)

Insider Trading Alert - CFX, ARWR And FMI Traded By Insiders
at The Street - Thu Jan 15, 9:30AM CST
Stocks with insider trader activity include CFX, ARWR and FMI
FMI: 48.88 (+0.17), ARWR: 6.77 (+0.21), CFX: 52.02 (+3.84)

Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 5:20PM CST
Oncology major, Roche (RHHBY) recently announced that it has entered into a strategic collaboration agreement to acquire up to a 56.3% stake in Foundation Medicine, Inc. (FMI), a molecular information and genomic analysis company.
AGN: 229.49 (+1.87), JNJ: 99.62 (+1.18), FMI: 48.88 (+0.17), NVS: 102.20 (-0.17)

Goodyear Tire and KB Home are big market movers
AP - Tue Jan 13, 3:43PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
PCYC: 163.28 (+0.23), IHS: 119.69 (+0.21), OCN: 9.10 (+0.09), BBW: 20.94 (+0.14), TKMR: 21.45 (-0.22), BMY: 60.04 (+0.56), TIF: 89.05 (+0.95), TKM.TO: 26.51 (-0.73), ELX: 6.57 (+0.22), GT: 25.91 (-0.30), FMI: 48.88 (+0.17), SHPG: 239.82 (+6.11), NPSP: 45.88 (+0.03), BNCL: 11.54 (-0.02), CVX: 112.78 (+1.92)

Will Foundation Medicine (FMI) Stock be Helped Today by This Price Target Increase?
at The Street - Tue Jan 13, 9:39AM CST
Foundation Medicine (FMI) shares are declining today, one session after the stock price doubled.
FMI: 48.88 (+0.17)

Stock Market News for January 13, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 9:10AM CST
Markets ended in the red zone for the second-consecutive day on Monday as oil price slide continued to dent investor sentiment
AA: 15.81 (+0.16), GS: 189.00 (-0.78), FMI: 48.88 (+0.17), SHPG: 239.82 (+6.11), HAL: 44.19 (+1.42), NPSP: 45.88 (+0.03), CVX: 112.78 (+1.92), LULU: 65.98 (-0.06), SNDK: 82.81 (+0.51), SLB: 88.38 (+2.42)

Foundation Medicine (FMI) Stock Gains Today on Merger Announcement
at The Street - Mon Jan 12, 2:30PM CST
Foundation Medicine (FMI) shares are rising after Roche Holding (RHHBY) announced that it was purchasing a 56.3% stake in the company.
FMI: 48.88 (+0.17)

Stocks Sink as Wall Street 'Fixates' on Stabilization in Oil Prices
at The Street - Mon Jan 12, 1:38PM CST
Oil continues to pressure stock markets on Monday following a price warning from Goldman Sachs analysts.
BIIB: 391.66 (-0.45), SN: 15.21 (-0.12), TIF: 89.05 (+0.95), LULU: 65.98 (-0.06), XLV: 70.72 (+0.28), AA: 15.81 (+0.16), FMI: 48.88 (+0.17), BBG: 12.56 (+0.55), AOL: 41.78 (+1.22), SHPG: 239.82 (+6.11), NPSP: 45.88 (+0.03), REXX: 5.08 (+0.13), BAS: 7.28 (+0.62), SNDK: 82.81 (+0.51), XLE: 82.04 (+1.70)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 11:46AM CST

CLUB: 6.94 (+0.10), FRO: 2.96 (+0.07), NES: 3.52 (+0.13), ARWR: 6.77 (+0.21), BBW: 20.94 (+0.14), TKMR: 21.45 (-0.22), NADL: 2.10 (-0.02), TIF: 89.05 (+0.95), BITA: 62.95 (+2.85), CPXX: 3.10 (+0.07), AGEN: 5.03 (-0.01), TOPS: 1.14 (+0.02), IRMD: 14.61 (-0.35), FMI: 48.88 (+0.17), SRPT: 12.76 (+0.11), REXX: 5.08 (+0.13), LOCM: 0.65 (-0.03), BLFS: 2.14 (+0.06), SNDK: 82.81 (+0.51), AWX: 3.50 (+0.10)

Why Shares of Foundation Medicine, Inc. Skyrocketed Today
George Budwell, The Motley Fool - Motley Fool - Mon Jan 12, 10:52AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of Foundation Medicine rose by more than...
FMI: 48.88 (+0.17), AZN: 69.96 (+0.20), EXAS: 25.56 (-0.54), BMY: 60.04 (+0.56)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

DC Renovation and Remodeling Earns Top Client Ratings Recognition

Updated Category News Views 195

DC Renovation and Remodeling Celebrated for Client Satisfaction DC Renovation and Remodeling has achieved noteworthy recognition from Find Local Contractors, being named a Top Client Rated Kitchen and Basement Renovation Contractor. This accolade is based on the company’s impressive five-star reviews from delighted customers, illustrating their dedication to exceptional...

Continue Reading
Neuronetics Achieves Remarkable Growth in Financial Performance

Updated Category News Views 135

Neuronetics' Impressive Financial Growth in Q2 2025 Neuronetics, Inc., a leader in neurohealth technology, announced its financial and operational achievements for the second quarter of 2025, showcasing remarkable results that signal a new era of success for the company. Quarterly Highlights and Financial Performance During the second quarter of 2025, Neuronetics reported...

Continue Reading
Understanding Market Sentiment Around Lemonade's Short Interest

Updated Category News Views 272

Insight Into Lemonade's Market Short Interest Lemonade's LMND short interest has increased recently, reflecting growing market observations. The latest reports indicate that there are approximately 17.65 million shorted shares, equating to about 31.95% of the total available shares for trading. With current trading volumes in mind, it would take traders roughly 7.63 days...

Continue Reading
SkinVision Pro: Transforming Dermatology Workflow Globally

Updated Category News Views 11

SkinVision Pro: Bridging Gaps in Dermatology There's a new sheriff in town for dermatology, and it's the SkinVision Pro. Launched at the HLTH Europe, this AI-powered platform is stepping up to modernize how skin health is managed globally. As skin cancer runs rampant with statistics that could send chills down anyone's spine, patient-doctor skin health communication...

Continue Reading
Lucid Group Reports Projected Loss Amid Investment Boost

Updated Category News Views 56

Lucid Group, the electric vehicle manufacturer, faced a harsh reality check back in 2024 when it announced an operational loss that came in way over estimates—between $765 million and $790 million for Q3. Just to put that into perspective, analysts were bracing for a loss of around $751.65 million, but Lucid threw them a curveball. The result? A 12% drop in its stock...

Continue Reading